however, these GLP-1 receptor agonists induce growth hormone secretion which stimulates the livers production of insulin-like growth factor-1 (IGF-1), which may be a cause of acne vulgaris development via sebum production
Among participants who were pre-diabetic at baseline, 73% achieved normal blood glucose levels at week 48, compared with 7.5% in the placebo group
Starting at the lower end (200-250mcg) allows tolerance assessment and side effect minimization before increasing to therapeutic doses, while taking doses higher than prescribed does not necessarily lead to additional benefit and may increase the risk of side effects due to physiologic feedback mechanisms
Chika Anekwe, the clinical director of obesity medicine at the Massachusetts General Hospital Weight Center, said the withdrawal of coverage of GLP-1s by insurers has caused chaos and panic for patients and doctors
De Flora, S., Balansky, R